Cargando…

Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT‐AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation)

BACKGROUND: The presence of valvular heart disease (VHD) may affect the risk of stroke and mortality in patients with atrial fibrillation (AF). Community‐based estimates of prevalence and outcomes of specific forms of VHD in patients with AF are lacking. METHODS AND RESULTS: We examined the prevalen...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Kevin L., Jackson, Larry R., Shrader, Peter, Ansell, Jack, Fonarow, Gregg C., Gersh, Bernard, Kowey, Peter R., Mahaffey, Kenneth W., Singer, Daniel E., Thomas, Laine, Piccini, Jonathan P., Peterson, Eric D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778999/
https://www.ncbi.nlm.nih.gov/pubmed/29273635
http://dx.doi.org/10.1161/JAHA.117.006475
_version_ 1783294454671605760
author Thomas, Kevin L.
Jackson, Larry R.
Shrader, Peter
Ansell, Jack
Fonarow, Gregg C.
Gersh, Bernard
Kowey, Peter R.
Mahaffey, Kenneth W.
Singer, Daniel E.
Thomas, Laine
Piccini, Jonathan P.
Peterson, Eric D.
author_facet Thomas, Kevin L.
Jackson, Larry R.
Shrader, Peter
Ansell, Jack
Fonarow, Gregg C.
Gersh, Bernard
Kowey, Peter R.
Mahaffey, Kenneth W.
Singer, Daniel E.
Thomas, Laine
Piccini, Jonathan P.
Peterson, Eric D.
author_sort Thomas, Kevin L.
collection PubMed
description BACKGROUND: The presence of valvular heart disease (VHD) may affect the risk of stroke and mortality in patients with atrial fibrillation (AF). Community‐based estimates of prevalence and outcomes of specific forms of VHD in patients with AF are lacking. METHODS AND RESULTS: We examined the prevalence of VHD, anticoagulation use, mortality, stroke/transient ischemic attack, and bleeding among a community cohort of patients with AF. Significant VHD was defined as follows: (1) moderate/severe mitral stenosis or mechanical valve; (2) bioprosthetic valve, surgical repair, or balloon valvuloplasty; and (3) moderate/severe aortic regurgitation or stenosis, mitral regurgitation, or tricuspid regurgitation. Proportional hazards models were performed to test the association between VHD groups and outcomes. Among 9748 patients with AF, 2705 (27.7%) had significant VHD. Anticoagulation use was highest among patients with mitral stenosis/mechanical valve (91.8%). Compared with individuals with no significant VHD, individuals with aortic regurgitation/aortic stenosis, mitral regurgitation, or tricuspid regurgitation (hazard ratio, 1.23; 95% confidence interval, 1.07–1.42) had the highest risk of death. There were no differences in stroke or transient ischemic attack and major bleeding among individuals with and without significant VHD. Patients with AF and aortic stenosis had the highest risk of death (hazard ratio, 1.32; 95% confidence interval, 1.08–1.62). CONCLUSIONS: Significant VHD is common among patients with AF in community practice. In a community cohort of patients with AF and CHA (2) DS (2)‐VASc score ≥2, most were anticoagulated. Individuals with AF and moderate‐to‐severe biological VHD have more comorbidities and a higher mortality risk; however, stroke and major bleeding are similar among those with and without significant VHD.
format Online
Article
Text
id pubmed-5778999
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-57789992018-01-26 Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT‐AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation) Thomas, Kevin L. Jackson, Larry R. Shrader, Peter Ansell, Jack Fonarow, Gregg C. Gersh, Bernard Kowey, Peter R. Mahaffey, Kenneth W. Singer, Daniel E. Thomas, Laine Piccini, Jonathan P. Peterson, Eric D. J Am Heart Assoc Original Research BACKGROUND: The presence of valvular heart disease (VHD) may affect the risk of stroke and mortality in patients with atrial fibrillation (AF). Community‐based estimates of prevalence and outcomes of specific forms of VHD in patients with AF are lacking. METHODS AND RESULTS: We examined the prevalence of VHD, anticoagulation use, mortality, stroke/transient ischemic attack, and bleeding among a community cohort of patients with AF. Significant VHD was defined as follows: (1) moderate/severe mitral stenosis or mechanical valve; (2) bioprosthetic valve, surgical repair, or balloon valvuloplasty; and (3) moderate/severe aortic regurgitation or stenosis, mitral regurgitation, or tricuspid regurgitation. Proportional hazards models were performed to test the association between VHD groups and outcomes. Among 9748 patients with AF, 2705 (27.7%) had significant VHD. Anticoagulation use was highest among patients with mitral stenosis/mechanical valve (91.8%). Compared with individuals with no significant VHD, individuals with aortic regurgitation/aortic stenosis, mitral regurgitation, or tricuspid regurgitation (hazard ratio, 1.23; 95% confidence interval, 1.07–1.42) had the highest risk of death. There were no differences in stroke or transient ischemic attack and major bleeding among individuals with and without significant VHD. Patients with AF and aortic stenosis had the highest risk of death (hazard ratio, 1.32; 95% confidence interval, 1.08–1.62). CONCLUSIONS: Significant VHD is common among patients with AF in community practice. In a community cohort of patients with AF and CHA (2) DS (2)‐VASc score ≥2, most were anticoagulated. Individuals with AF and moderate‐to‐severe biological VHD have more comorbidities and a higher mortality risk; however, stroke and major bleeding are similar among those with and without significant VHD. John Wiley and Sons Inc. 2017-12-22 /pmc/articles/PMC5778999/ /pubmed/29273635 http://dx.doi.org/10.1161/JAHA.117.006475 Text en © 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Thomas, Kevin L.
Jackson, Larry R.
Shrader, Peter
Ansell, Jack
Fonarow, Gregg C.
Gersh, Bernard
Kowey, Peter R.
Mahaffey, Kenneth W.
Singer, Daniel E.
Thomas, Laine
Piccini, Jonathan P.
Peterson, Eric D.
Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT‐AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation)
title Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT‐AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation)
title_full Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT‐AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation)
title_fullStr Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT‐AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation)
title_full_unstemmed Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT‐AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation)
title_short Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT‐AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation)
title_sort prevalence, characteristics, and outcomes of valvular heart disease in patients with atrial fibrillation: insights from the orbit‐af (outcomes registry for better informed treatment for atrial fibrillation)
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778999/
https://www.ncbi.nlm.nih.gov/pubmed/29273635
http://dx.doi.org/10.1161/JAHA.117.006475
work_keys_str_mv AT thomaskevinl prevalencecharacteristicsandoutcomesofvalvularheartdiseaseinpatientswithatrialfibrillationinsightsfromtheorbitafoutcomesregistryforbetterinformedtreatmentforatrialfibrillation
AT jacksonlarryr prevalencecharacteristicsandoutcomesofvalvularheartdiseaseinpatientswithatrialfibrillationinsightsfromtheorbitafoutcomesregistryforbetterinformedtreatmentforatrialfibrillation
AT shraderpeter prevalencecharacteristicsandoutcomesofvalvularheartdiseaseinpatientswithatrialfibrillationinsightsfromtheorbitafoutcomesregistryforbetterinformedtreatmentforatrialfibrillation
AT anselljack prevalencecharacteristicsandoutcomesofvalvularheartdiseaseinpatientswithatrialfibrillationinsightsfromtheorbitafoutcomesregistryforbetterinformedtreatmentforatrialfibrillation
AT fonarowgreggc prevalencecharacteristicsandoutcomesofvalvularheartdiseaseinpatientswithatrialfibrillationinsightsfromtheorbitafoutcomesregistryforbetterinformedtreatmentforatrialfibrillation
AT gershbernard prevalencecharacteristicsandoutcomesofvalvularheartdiseaseinpatientswithatrialfibrillationinsightsfromtheorbitafoutcomesregistryforbetterinformedtreatmentforatrialfibrillation
AT koweypeterr prevalencecharacteristicsandoutcomesofvalvularheartdiseaseinpatientswithatrialfibrillationinsightsfromtheorbitafoutcomesregistryforbetterinformedtreatmentforatrialfibrillation
AT mahaffeykennethw prevalencecharacteristicsandoutcomesofvalvularheartdiseaseinpatientswithatrialfibrillationinsightsfromtheorbitafoutcomesregistryforbetterinformedtreatmentforatrialfibrillation
AT singerdaniele prevalencecharacteristicsandoutcomesofvalvularheartdiseaseinpatientswithatrialfibrillationinsightsfromtheorbitafoutcomesregistryforbetterinformedtreatmentforatrialfibrillation
AT thomaslaine prevalencecharacteristicsandoutcomesofvalvularheartdiseaseinpatientswithatrialfibrillationinsightsfromtheorbitafoutcomesregistryforbetterinformedtreatmentforatrialfibrillation
AT piccinijonathanp prevalencecharacteristicsandoutcomesofvalvularheartdiseaseinpatientswithatrialfibrillationinsightsfromtheorbitafoutcomesregistryforbetterinformedtreatmentforatrialfibrillation
AT petersonericd prevalencecharacteristicsandoutcomesofvalvularheartdiseaseinpatientswithatrialfibrillationinsightsfromtheorbitafoutcomesregistryforbetterinformedtreatmentforatrialfibrillation